Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Abstract The objective of the study was to formulate a novel protein nanocarrier system for efficient oral delivery of exemestane
Judith Zarek and Dr
Fabricated beneath ISO9001 and ISO14001 certified offices, our product meets universal GMP measures with full SGS test reports
Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial
US$ 28.35
US$ 25.15
US$ 25.19
US$ 21.64
